Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 625-636

  Ozdemir, Aylin M ^a   Hopper, Ulrich ^a   Erhard, Penny ^a   Monnier, Vincent M ^b   Weiss, Miriam F ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Advanced glycation end products (AGEs); Diabetic nephropathy; Lysosomal function; Methylglyoxal (MGO) modified albumin; Protein processing; Proximal tubule

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; BOVINE SERUM ALBUMIN; LYSOSOME ENZYME; METHYLGLYOXAL;

CATABOLISM; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PROXIMAL TUBULE; MONOLAYER CULTURE; PATHOGENESIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; URINARY EXCRETION;

EID: 23744449861     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1338.071     Document Type: Conference Paper

References (66)

1. U.S. RENAL DATA SYSTEM. 2003. Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am. J. Kidney Dis. 42 (Suppl. 5): s37-s74.
2. RABKIN, R. 2003. Diabetic nephropathy. Clin. Cornerstone 5: 1-11.
3. LOCATELLI, F., P. POZZONI & L. DEL VECCHIO. 2004. Renal replacement therapy in patients with diabetes and end-stage renal disease. J. Am. Soc. Nephrol. 15: S25-S29.
4. CARAMORI, M., P. FIORETTO & M. MAUER. 2000. The need for early predictors of diabetic nephropathy risk. Is albumin excretion rate sufficient? Diabetes 49: 1399-1408.
5. THE DIABETES CONTROL AND COMPLICATIONS RESEARCH GROUP. 1995. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 47: 1703-1720.
6. THE DIABETES CONTROL AND COMPLICATIONS TRIAL/EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS RESEARCH GROUP. 2000. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 342: 381-389.
7. WARRAM, J. et al. 1996. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J. Am. Soc. Nephrol. 7: 930-937.
8. MOGENSEN, C. & C. CHRISTENSEN. 1984. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311: 89-93.
9. LEWIS, E. et al. 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329: 1456-1462.
10. WOLF, G. 1999. Angiotensin II: pivotal factor in the progression of renal diseases. Nephrol. Dial. Transplant. 14: 42-44.
11. HIRATSUKA, N. et al. 1998. Analysis of urinary albumin, transferrin, N-acetyl-β-D-glycosaminidase and β2 microglobulin in patients with impaired glucose tolerance. J. Clin. Lab. Anal. 12: 351-355.
12. MAUER, S. et al. 1984. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143-1155.
13. CHAVERS, B. et al. 1989. Glomerular lesions and urinary albumin excretion in type 1 diabetic patients without overt proteinuria. N. Engl. J. Med. 320: 966-970.
14. LANE, P. et al. 1993. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int. 43: 661-667.
15. NORDEN, A. et al. 2001. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int. 60: 1885-1892.
16. TOJO, A. & H. ENDOU. 1992. Intrarenal handling of protein in rats using fractional micropuncture technique. Am. J. Physiol. 263: F601-F606.
17. EPPEL, G. et al. 2001. The return of glomerular filtered albumin to the rat renal vein-the albumin retrieval pathway. Renal Failure 23: 347-363.
18. Russo, L., G. BAKRIS & W. COMPER. 2002. Renal handling of albumin: a critical review of basic concepts and perspective. Am. J. Kidney Dis. 39: 899-919.
19. OSICKA, T. et al. 2000. Albuminuria in patients with Type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 49: 1579-1584.
20. GUDEHITHLU, K. et al. 2004. Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments. Kidney Int. 65: 2113-2122.
21. HONG, C. & K. CHIA. 1998. Markers of diabetic nephropathy. J. Diabet. Complications 12: 143-160.
22. TUCKER, B., R. RASCH & R. BLANTZ. 1993. Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats. J. Clin. Invest. 92: 686-694.
23. OSICKA, T. et al. 2001. Ramipril and aminoguanidine restore renal Iysosomal processing in streptozotocin diabetic rats. Diabetologia 44: 230-236.
24. LONDONO, I. & M. BENDAYAN. 2001. Temporary effects of circulating Amadori products on glomerular filtration properties in the normal mouse. Am. J. Physiol. Renal Physiol. 280: F103-F111.
25. KOWLURU, A. et al. 1987. Suggested mechanism for the selective excretion of glycosylated albumin. J. Exp. Med. 166: 1259-1279.
26. LAYTON, G. & G. JERUMS. 1988. Effect of glycation of albumin on its renal clearance in normal and diabetic rats. Kidney Int. 33: 673-676.
27. XIANG, G. et al. 2001. Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin. Kidney Int. 78: S53-S57.
28. BROWNLEE, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
29. WESTWOOD, M., A. MCLELLAN & P. THORNALLEY. 1994. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor. J. Biol. Chem. 269: 32293-32298.
30. WESTWOOD, M. & P. THORNALLEY. 1995. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparisons with glucose-derived advanced glycation endproduct-modified serum albumins. J. Prot. Chem. 14: 359-372.
31. FAN, X.-J. et al. 2003. Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappa B and intracellular reactive oxygen species formation. Arch. Biochem. Biophys. 409: 274-286.
32. SUBRAMANIAM, R. et al. 2002. Cellular oxidant stress and advanced glycation endproducts of albumin: caveats of the dichloro-fluorescein assay. Arch. Biochem. Biophys. 400: 15-25.
33. OROSZ, D. et al. 2004. Growth, immortalization, and differentiation potential of normal adult human proximal tubule cells. In Vitro Cell. Dev. Biol. Anim. 40: 22-34.
34. WOOST, P. et al. 1996. Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidney Int. 50: 125-134.
35. RACUSEN, L. et al. 1997. Cell lines with extended growth potential from human renal proximal tubule: Characterization, response to inducers and comparison with established cell lines. J. Lab. Clin. Med. 129: 318-329.
36. JARAD, G. et al. 2002. Fas activation induces renal tubular epithelial cell beta 8 integrin expression and function in the absence of apoptosis. J. Biol. Chem. 277: 47826-47833.
37. OLDFIELD, M. et al. 2001. Advanced glycation end products cause epithelial myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J. Clin. Invest. 108: 1853-1863.
38. JUNG, F. et al. 1998. Immortalized rat proximal tubule cells produce membrane bound and soluble megalin. Kidney Int. 53: 358-366.
39. NIELSEN, R. et al. 1998. Characterization of a kidney proximal tubule cell line, LLC-PK1, expressing endocytotic active megalin. J. Am. Soc. Nephrol. 9: 1767-1776.
40. + exchange decreases albumin-induced NF-κB activation in renal proximal tubular cell lines (OK and LLC-PK1 Cells). Eur. J. Med. Res. 6: 422-432.
41. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellilus. N. Engl. J. Med. 329: 977-986.
42. THE DIABETES CONTROL AND COMPLICATIONS RESEARCH GROUP. 1993. Baseline analysis of renal function in the Diabetes Control and Complications Trial. Kidney Int. 43: 668-674.
43. SHIBATA, H. & T. YAGI. 1996. Rate assay of N-acelyl-β-D- hexoasaminidase with 4-nitrophenyl N-acetyl-β-D-glucosaminide as an artificial substrate. Clin. Chem. Acta 251: 53-64.
44. MORITA, A. et al. 1998. Stabilities of N-acetyl β-D-glucosaminidase (NAG) isoenzymes in urine: advantage of NAG isoenzyme B measurement in clinical applications. Clin. Chem. Acta 278: 35-43.
45. MCDONOUGH, A. & D. BIEMESDERFER. 2003. Does membrane trafficking play a role in regulating the sodium/hydrogen exchanger isoform 3 in the proximal tubule? Curr. Opin. Nephrol. Hypertens. 12: 533-541.
46. DAUTRY-VARSAT, A. & H. LODISH. 1984. How receptors bring proteins and particles into cells. Sci. Am. 250: 52-58.
47. PARK, C. & T. MAACK. 1984. Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J. Clin. Invest. 73: 767-777.
48. CHRISTENSEN, E. & H. BIRN. 2001. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am. J. Physiol. 280: F562-F573.
49. SAITO, A. et al. 2003. Role of megalin in endocytosis of advanced glycation end products: implications for a novel protein binding to both megalin and advanced glycation end products. J. Am. Soc. Nephrol. 14: 1123-1131.
50. CRIDER-PIRKLE, S. et al. 2002. Cubilin, a binding partner for Galectin-3 in the murine utero-placental complex. J. Biol. Chem. 277: 15904-15912.
51. MARSHANSKY, V. et al. 1997. Receptor-mediated endocytosis in kidney proximal tubules: recent advances and hypothesis. Electrophoresis 18: 2661-2676.
52. GEKLE, M. et al. 1999. Inhibition of Na-H exchange impairs receptor-mediated albumin endocytosis in renal proximal tubule-derived epithelial cells from opossum. J. Physiol. 520: 709-721.
53. GEKLE, M., R. FERUDINGER & S. MILDENBERGER. 2001. Inhibition of Na,H exchanger-3 interferes with apical-receptor mediated endocytosis via vesicle fusion. J. Physiol. 531: 619-629.
54. CARONE, F. et al. 1979. Renal tubular transport and catabolism of proteins and peptides. Kidney Int. 16: 271-278.
55. GUGLIUCCI, A. & M. BENDAYAN. 1996. Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39: 149-160.
56. GUGLIUCCI, A. & T. MENINI. 1998. Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains. Life Sci. 62: 2141-2150.
57. IKENAGA, H. et al. 1993. Enzymuria in non-insulin-dependent diabetic patients: signs of tubular cell dysfunction. Clin. Sci. 84: 469-475.
58. SCHULTZ, C. et al. 2001. Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of type 1 diabetes. Diabetologia 44: 224-229.
59. UK PROSPECTIVE DIABETES STUDY GROUP. 1993. Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of Type 2 (non-insulin dependent) diabetes mellitus and after 3 months of diet therapy. Diabetologia 36: 835-842.
60. NAVARRO, J. et al. 2003. Effects of pentoxifylline administration on urinary N-acetyl-β-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study. Am. J. Kidney Dis. 42: 264-270.
61. MONNIER, V. et al. 1999. Skin collagen glycation, glycoxidation and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48: 870-880.
62. 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 25: 280-287.
63. FRANCH, H., P. CURTIS & W. MITCH. 1997. Mechanisms of renal tubular cell hypertrophy: mitogen-induced suppression of proteolysis. Am. J. Physiol. 273: C843-C851.
64. FRANCH, H., S. SOOPARB & J. DU. 2001. A mechanism regulating proteolysis of specific proteins during renal tubular cell growth. J. Biol. Chem. 276: 19126-19131.
65. BERRY, G. et al. 1995. Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome. Pediatr. Nephrol. 9: 287-291.
66. MARSHANSKY, V., D. AUSIELLO & D. BROWN. 2002. Physiological importance of endosomal acidification: potential role in proximal tubulopathies. Curr. Opin. Nephrol. Hypertens. 11: 527-537.